Lamine Mbow
-
Boehringer Ingelheim, 3T Biosciences to develop next gencancer immunotherapies
Boehringer Ingelheim will provide patient-derived TCR data to fuel 3T’s target discovery efforts to identify antigens using its 3T TRACE…
Read More »